N-((S)-1-((S)-2-(1H-tetrazol-5-yl)pyrrolidin-1-yl)-1-oxopropan-2-yl)-N-methyl-4-phenylbutanamide

ID: ALA4464018

Chembl Id: CHEMBL4464018

PubChem CID: 155530046

Max Phase: Preclinical

Molecular Formula: C19H26N6O2

Molecular Weight: 370.46

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  C[C@@H](C(=O)N1CCC[C@H]1c1nnn[nH]1)N(C)C(=O)CCCc1ccccc1

Standard InChI:  InChI=1S/C19H26N6O2/c1-14(19(27)25-13-7-11-16(25)18-20-22-23-21-18)24(2)17(26)12-6-10-15-8-4-3-5-9-15/h3-5,8-9,14,16H,6-7,10-13H2,1-2H3,(H,20,21,22,23)/t14-,16-/m0/s1

Standard InChI Key:  CBDZVTZGWAARJV-HOCLYGCPSA-N

Alternative Forms

  1. Parent:

    ALA4464018

    ---

Associated Targets(Human)

HEK293 (82097 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

PREP Prolyl endopeptidase (246 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Prep Prolyl endopeptidase (55 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 370.46Molecular Weight (Monoisotopic): 370.2117AlogP: 1.73#Rotatable Bonds: 7
Polar Surface Area: 95.08Molecular Species: ACIDHBA: 5HBD: 1
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 4.04CX Basic pKa: CX LogP: 1.50CX LogD: -0.11
Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.80Np Likeness Score: -1.03

References

1. Kilpeläinen TP, Tyni JK, Lahtela-Kakkonen MK, Eteläinen TS, Myöhänen TT, Wallén EAA..  (2019)  Tetrazole as a Replacement of the Electrophilic Group in Characteristic Prolyl Oligopeptidase Inhibitors.,  10  (12): [PMID:31857839] [10.1021/acsmedchemlett.9b00394]
2. Pätsi HT, Kilpeläinen TP, Auno S, Dillemuth PMJ, Arja K, Lahtela-Kakkonen MK, Myöhänen TT, Wallén EAA..  (2021)  2-Imidazole as a Substitute for the Electrophilic Group Gives Highly Potent Prolyl Oligopeptidase Inhibitors.,  12  (10.0): [PMID:34671446] [10.1021/acsmedchemlett.1c00399]

Source